PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Pacific Bio (PACB) Misses Q4 EPS by 2c
February 15, 2022 4:14 PM ESTPacific Bio (NASDAQ: PACB) reported Q4 EPS of ($0.30), $0.02 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $36 million versus the consensus estimate of $36.12 million.
For earnings history and earnings-related data on Pacific Bio (PACB) click here.
... More